HLA-B*0801-binding EBV peptide

This synthetic peptide, corresponding to the EBV epitope FLRGRAYGL, is presented by HLA-B0801 to activate epitope-specific CD8+ T cells. It is a key research tool for studying antiviral immunity, T cell receptor interactions, and immune monitoring in both in vitro and in vivo experimental models.